Interleukin 17 deficiency and implications in cutaneous and systemic diseases
Background: IL17-targeted therapeutics are being developed to treat psoriasis. IL17 is involved in the pathogenesis of many diseases, and the implications of IL17 blockade are not yet well characterized. Objective: To review the implications of IL17 deficiency to determine potential implications of...
Saved in:
Main Authors: | Elizabeth Z. Welch (Author), Kathryn L. Anderson (Author), Steven R. Feldman (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2015-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The expression of interleukin-17 in cutaneous lesions of lupus erythematosus in pediatric-onset systemic lupus erythematosus
by: Govind Suresh Mittal, et al.
Published: (2017) -
Interleukin-17 Genes Polymorphisms are Significantly Associated with Cutaneous T-cell Lymphoma Susceptibility
by: Karol Kołkowski, et al.
Published: (2022) -
Targeting of interleukin-17 in the treatment of psoriasis
by: Lønnberg AS, et al.
Published: (2014) -
A Mechanistic Insight into the Pathogenic Role of Interleukin 17A in Systemic Autoimmune Diseases
by: Radjesh Bisoendial, et al.
Published: (2022) -
Interleukin-17 and Its Implication in the Regulation of Differentiation and Function of Hematopoietic and Mesenchymal Stem Cells
by: Slavko Mojsilović, et al.
Published: (2015)